
Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.
Save your seatBFLY ran from roughly $4.04 in late March to about $5.49 by April 16, 2026 off FDA clearance for its gestational age ultrasound AI tool and a strong Q1 setup.
The stock has the potential to go down if it loses $4.20 and fails to reclaim it, which could open a retrace toward $3.60 to $3.80. Any soft follow-through on HomeCare commercialization or selling pressure tied to the planned July 14, 2026 Rule 10b5-1 insider sale window would add pressure.
If BFLY holds the $4.20 to $4.40 area, a move back toward $5.25 to $5.70 is on the table as traders lean on FDA momentum and 25% year over year revenue growth. Resistance at $4.80 is the first hurdle.
We don't currently have information about Butterfly Network Inc. Class A's earnings.